These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28544422)

  • 21. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding rates of Veterans taking apixaban or rivaroxaban for atrial fibrillation or venous thromboembolism.
    Howe Z; Naville-Cook C; Cole D
    J Thromb Thrombolysis; 2019 Feb; 47(2):280-286. PubMed ID: 30449001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.
    Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A
    Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis.
    Lega JC; Mismetti P; Cucherat M; Fassier T; Bertoletti L; Chapelle C; Laporte S
    J Thromb Haemost; 2013 Jul; 11(7):1240-50. PubMed ID: 23659614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of new oral anticoagulants compared to those of warfarin in AF patients with cancer: a meta-analysis of randomized clinical trials and observational studies.
    Chen Y; Mao M; Chang J; Yan J; Yang T; Liu Y; Luo M; Hu Y; Yang Q; Zhou L; Ma K
    Eur J Clin Pharmacol; 2021 Jun; 77(6):849-857. PubMed ID: 33791828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis.
    Drescher FS; Sirovich BE; Lee A; Morrison DH; Chiang WH; Larson RJ
    J Hosp Med; 2014 Sep; 9(9):579-85. PubMed ID: 25045166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention.
    Camm AJ; Fox KAA; Peterson E
    Europace; 2018 Jan; 20(1):1-11. PubMed ID: 29040518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality.
    Kilo R; Laporte S; Arab R; Mainbourg S; Provencher S; Grenet G; Bertoletti L; Villeneuve L; Cucherat M; Lega JC;
    Sci Rep; 2021 Jul; 11(1):14728. PubMed ID: 34282198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of warfarin in "high-risk" populations: A meta-analysis of randomized and controlled trials.
    Di Minno MN; Ambrosino P; Dentali F
    Thromb Res; 2017 Feb; 150():1-7. PubMed ID: 27988374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefit-to-harm ratio of thromboprophylaxis for patients undergoing major orthopaedic surgery. A systematic review.
    Hull RD; Liang J; Bergqvist D; Yusen RD
    Thromb Haemost; 2014 Feb; 111(2):199-212. PubMed ID: 24154501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
    Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
    J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis.
    Presume J; Ferreira J; Ribeiras R; Mendes M
    J Thromb Haemost; 2022 Dec; 20(12):2930-2938. PubMed ID: 36128769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.
    Lilli A; Di Cori A; Zacà V
    Clin Cardiol; 2017 Sep; 40(9):641-647. PubMed ID: 28471498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding risk of patients with acute venous thromboembolism taking nonsteroidal anti-inflammatory drugs or aspirin.
    Davidson BL; Verheijen S; Lensing AW; Gebel M; Brighton TA; Lyons RM; Rehm J; Prins MH
    JAMA Intern Med; 2014 Jun; 174(6):947-53. PubMed ID: 24733305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
    Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.
    Gorog DA; Gue YX; Chao TF; Fauchier L; Ferreiro JL; Huber K; Konstantinidis SV; Lane DA; Marin F; Oldgren J; Potpara T; Roldan V; Rubboli A; Sibbing D; Tse HF; Vilahur G; Lip GYH
    Europace; 2022 Nov; 24(11):1844-1871. PubMed ID: 35323922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Sobieraj DM; Coleman CI; Pasupuleti V; Deshpande A; Kaw R; Hernandez AV
    Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.